Bioequivalence of Tramadol retard 200 mg Prolonged-Release Tablets in Healthy Subjects Under Fed Conditions

2026-525780-41-00 Protocol CFA-1049-1-25 Human pharmacology (Phase I) - Bioequivalence study Ongoing, recruiting

Start 22 Jun 2026 · Status Ongoing, recruiting · 1 EU/EEA countries · 1 sites · Protocol CFA-1049-1-25

Overview

Sponsor-declared trial summary

Phase Human pharmacology (Phase I) - Bioequivalence study
Status Ongoing, recruiting
Participants planned 36
Countries 1
Sites 1

Not applicable (submitted trial is a bioavailability trial in healthy participants).

Key facts

Sponsor
Laboratorios Cinfa S.A.
Participant type
Healthy volunteers
Age range
18-64 years
Gender
Male and Female
Therapeutic area
Diseases [C] - Nervous System Diseases [C10]
Trial duration
22 Jun 2026 → ongoing
Decision date (initial)
2026-06-04
Transition trial
No
Low-intervention
No
Rare-disease indication
No
Vulnerable population
Yes

Trial design

CTIS Part I — objectives, methods, condition coding

Conditions and MedDRA coding

Not applicable (submitted trial is a bioavailability trial in healthy participants).

VersionLevelCodeTermSystem organ class
20.0 PT 10033371 Pain 100000004867

Sponsors and contacts

Sponsor organisations, regulatory contacts, third parties

Laboratorios Cinfa S.A.

Sponsor organisation
Laboratorios Cinfa S.A.
Address
Travesia De Roncesvalles 1, Olloki Olloki
City
Esteribar
Postcode
31699
Country
Spain

Scientific contact point

Organisation
Laboratorios Cinfa S.A.
Contact name
Manuel Escolar Jurado

Public contact point

Organisation
Laboratorios Cinfa S.A.
Contact name
Manuel Escolar Jurado

Locations

1 EU/EEA country · 1 investigational sites

By country

CountryMS statusPlanned subjectsSites
Czechia Ongoing, recruiting 36 1
Rest of world 0

Investigational sites

Czechia

1 site · Ongoing, recruiting
Quinta-Analytica s.r.o.
Clinical Unit, Prazska 1486/18c, Hostivar, Prague

Country notifications

Trial-start, recruitment-start, end and early-termination notifications submitted per Member State

Country Trial startTrial end Recruitment startRecruitment end Early termination
Czechia 2026-06-22 2026-06-22

Application history

1 submissions — initial application plus substantial / non-substantial modifications

#TypeCodeSubmittedReference MSConclusionDecision date
1 INITIAL IN 2026-05-05 Czechia Acceptable
2026-06-03
2026-06-04